Only Trump's nod remains for PDUFA after near-unanimous Senate vote

The Prescription Drug User Fee Act (PDUFA) has passed its final congressional hurdle, with approval in the US Senate coming three weeks after the House of Representatives greenlit the quinquennial reauthorization bill.

Former Democratic presidential candidate Bernie Sanders was the only senator to vote against the bill.

The act will enable the US Food and Drug Administration to collect an estimated $9 billion in fees over five years, more than a quarter of all FDA funding, in return for processing drug applications.